{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:54:37Z","timestamp":1774418077985,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMUH111-REC2-035"],"award-info":[{"award-number":["CMUH111-REC2-035"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijid.2026.108492","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:28:41Z","timestamp":1771288121000},"page":"108492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of vancomycin or teicoplanin gram-positive prophylaxis with infection profile and mortality in ECMO patients: A real-world cohort study"],"prefix":"10.1016","volume":"165","author":[{"given":"You-Cian","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Chun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsin","family":"Muo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.ijid.2026.108492_bib0001","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","article-title":"Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome","volume":"378","author":"Combes","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ijid.2026.108492_bib0002","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/PCC.0b013e3181e28894","article-title":"Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults","volume":"12","author":"Bizzarro","year":"2011","journal-title":"Pediatr Crit Care Med"},{"issue":"12","key":"10.1016\/j.ijid.2026.108492_bib0003","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/cid\/cis783","article-title":"Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation","volume":"55","author":"Schmidt","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108492_bib0004","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhin.2009.07.016","article-title":"Risk factors for nosocomial infection during extracorporeal membrane oxygenation","volume":"73","author":"Hsu","year":"2009","journal-title":"J Hosp Infect"},{"issue":"7","key":"10.1016\/j.ijid.2026.108492_bib0005","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s001340101029","article-title":"Nosocomial infections during extracorporeal membrane oxygenation","volume":"27","author":"O'Neill","year":"2001","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.ijid.2026.108492_bib0006","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13613-017-0335-9","article-title":"Venovenous extracorporeal membrane oxygenation devices-related colonisations and infections","volume":"7","author":"Thomas","year":"2017","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.ijid.2026.108492_bib0007","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MAT.0000000000000308","article-title":"Infections and extracorporeal membrane oxygenation: incidence, therapy, and outcome","volume":"62","author":"Haneke","year":"2016","journal-title":"ASAIO J"},{"issue":"4","key":"10.1016\/j.ijid.2026.108492_bib0008","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/08850666221128243","article-title":"Prevalence and Impact of Infection during Extracorporeal Membrane Oxygenation in Oncologic Patients: A Retrospective Analysis of the Extracorporeal Life Support Organization (ELSO) Registry","volume":"38","author":"Suzuki","year":"2023","journal-title":"J Intensive Care Med"},{"issue":"4","key":"10.1016\/j.ijid.2026.108492_bib0009","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/microorganisms11041079","article-title":"Nosocomial infections in adult patients supported by extracorporeal membrane oxygenation in a cardiac intensive care unit","volume":"11","author":"Mornese Pinna","year":"2023","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.ijid.2026.108492_bib0010","first-page":"480","article-title":"Nosocomial infections during extracorporeal membrane oxygenation","volume":"28","author":"Mart\u00ednez-Mart\u00ednez","year":"2022","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"10.1016\/j.ijid.2026.108492_bib0011","article-title":"Clinical and microbiological characteristics of and risk factors for bloodstream infections among patients with extracorporeal membrane oxygenation: a single-center retrospective cohort study","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ijid.2026.108492_bib0012","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13054-024-04946-8","article-title":"Incidence, risk factors and outcomes of nosocomial infection in adult patients supported by extracorporeal membrane oxygenation: a systematic review and meta-analysis","volume":"28","author":"Ait Hssain","year":"2024","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.ijid.2026.108492_bib0013","doi-asserted-by":"crossref","first-page":"R194","DOI":"10.1186\/cc11679","article-title":"Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation","volume":"16","author":"Shekar","year":"2012","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.ijid.2026.108492_bib0014","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13054-015-0891-z","article-title":"Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study","volume":"19","author":"Shekar","year":"2015","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.ijid.2026.108492_bib0015","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1186\/s13054-020-03397-1","article-title":"Antibiotic therapeutic drug monitoring in intensive care patients treated with different modalities of extracorporeal membrane oxygenation (ECMO) and renal replacement therapy: a prospective, observational single-center study","volume":"24","author":"K\u00fchn","year":"2020","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.ijid.2026.108492_bib0016","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s13054-024-05101-z","article-title":"A narrative review on antimicrobial dosing in adult critically ill patients on extracorporeal membrane oxygenation","volume":"28","author":"Kim","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.ijid.2026.108492_bib0017","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.hrtlng.2023.02.020","article-title":"Treatment and outcome of gram-positive bacteremia in patients receiving extracorporeal membrane oxygenation","volume":"60","author":"Marcus","year":"2023","journal-title":"Heart Lung"},{"issue":"11","key":"10.1016\/j.ijid.2026.108492_bib0018","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1513\/AnnalsATS.202008-974OC","article-title":"Efficacy of Prophylactic Antibiotics during Extracorporeal Membrane Oxygenation: A Nationwide Cohort Study","volume":"18","author":"Kondo","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"10.1016\/j.ijid.2026.108492_bib0019","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1513\/AnnalsATS.202111-1290LE","article-title":"Antimicrobial prophylaxis in extracorporeal membrane oxygenation: is the debate still open?","volume":"19","author":"Montrucchio","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.ijid.2026.108492_bib0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MAT.0000000000000308","article-title":"Infections and Extracorporeal Membrane Oxygenation: Incidence, Therapy, and Outcome","volume":"62","author":"Haneke","year":"2016","journal-title":"ASAIO J"},{"issue":"1","key":"10.1016\/j.ijid.2026.108492_bib0021","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s12871-024-02796-z","article-title":"Do patients receiving extracorporeal membrane-oxygenation need antibiotic prophylaxis? A systematic review and meta-analysis on 7,996 patients","volume":"24","author":"Orso","year":"2024","journal-title":"BMC Anesthesiol"},{"issue":"3","key":"10.1016\/j.ijid.2026.108492_bib0022","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MAT.0b013e31820d19ab","article-title":"Antimicrobial prophylaxis and infection surveillance in extracorporeal membrane oxygenation patients: a multi-institutional survey of practice patterns","volume":"57","author":"Kao","year":"2011","journal-title":"ASAIO J"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2026.108492_bib0023","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history","volume":"42","author":"Levine","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2026.108492_bib0024","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/jac\/dkab499","article-title":"Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"77","author":"Hanai","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"24","key":"10.1016\/j.ijid.2026.108492_bib0025","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ijid.2026.108492_bib0026","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.chom.2019.10.011","article-title":"Recovery of the Gut Microbiota after Antibiotics Depends on Host Diet, Community Context, and Environmental Reservoirs","volume":"26","author":"Ng","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijid.2026.108492_bib0027","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.2147\/IDR.S319780","article-title":"Surgical Antibiotic Prophylaxis in an Era of Antibiotic Resistance: Common Resistant Bacteria and Wider Considerations for Practice","volume":"14","author":"Menz","year":"2021","journal-title":"Infect Drug Resist"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122600127X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122600127X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:59:53Z","timestamp":1774414793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S120197122600127X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":27,"alternative-id":["S120197122600127X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108492","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of vancomycin or teicoplanin gram-positive prophylaxis with infection profile and mortality in ECMO patients: A real-world cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108492"}}